CN112274107B - Puncture site hematoma detection platform - Google Patents
Puncture site hematoma detection platform Download PDFInfo
- Publication number
- CN112274107B CN112274107B CN202010616382.6A CN202010616382A CN112274107B CN 112274107 B CN112274107 B CN 112274107B CN 202010616382 A CN202010616382 A CN 202010616382A CN 112274107 B CN112274107 B CN 112274107B
- Authority
- CN
- China
- Prior art keywords
- hematoma
- tube body
- contrast
- blood
- punctured
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010018852 Haematoma Diseases 0.000 title claims abstract description 102
- 238000001514 detection method Methods 0.000 title claims abstract description 26
- 239000008280 blood Substances 0.000 claims abstract description 53
- 210000004369 blood Anatomy 0.000 claims abstract description 53
- 230000007246 mechanism Effects 0.000 claims abstract description 37
- 210000004185 liver Anatomy 0.000 claims abstract description 21
- 230000009471 action Effects 0.000 claims abstract description 4
- 238000012545 processing Methods 0.000 claims description 28
- 238000004891 communication Methods 0.000 claims description 18
- 239000003086 colorant Substances 0.000 claims description 3
- 230000004069 differentiation Effects 0.000 claims description 3
- 230000000717 retained effect Effects 0.000 claims description 3
- 230000002159 abnormal effect Effects 0.000 claims description 2
- 238000013500 data storage Methods 0.000 claims description 2
- 238000004321 preservation Methods 0.000 claims description 2
- 210000001367 artery Anatomy 0.000 abstract description 12
- 210000004204 blood vessel Anatomy 0.000 abstract description 4
- 210000003462 vein Anatomy 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 description 8
- 238000012360 testing method Methods 0.000 description 8
- 230000002861 ventricular Effects 0.000 description 8
- 238000002583 angiography Methods 0.000 description 6
- 239000012530 fluid Substances 0.000 description 5
- 210000001105 femoral artery Anatomy 0.000 description 4
- 239000002872 contrast media Substances 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- 210000000115 thoracic cavity Anatomy 0.000 description 3
- 208000002403 Encephalocele Diseases 0.000 description 2
- 230000002490 cerebral effect Effects 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 230000007547 defect Effects 0.000 description 2
- 230000005684 electric field Effects 0.000 description 2
- 230000006698 induction Effects 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 230000003601 intercostal effect Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 238000010295 mobile communication Methods 0.000 description 2
- 210000003625 skull Anatomy 0.000 description 2
- 210000000278 spinal cord Anatomy 0.000 description 2
- 210000001321 subclavian vein Anatomy 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 210000002385 vertebral artery Anatomy 0.000 description 2
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- 206010059245 Angiopathy Diseases 0.000 description 1
- 206010010071 Coma Diseases 0.000 description 1
- 206010015769 Extradural haematoma Diseases 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 206010052098 Iodine allergy Diseases 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 208000002667 Subdural Hematoma Diseases 0.000 description 1
- 208000000573 Supratentorial Neoplasms Diseases 0.000 description 1
- 208000009443 Vascular Malformations Diseases 0.000 description 1
- 239000003570 air Substances 0.000 description 1
- 210000002376 aorta thoracic Anatomy 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 210000001168 carotid artery common Anatomy 0.000 description 1
- 238000002585 cerebral angiography Methods 0.000 description 1
- 210000004289 cerebral ventricle Anatomy 0.000 description 1
- 210000001175 cerebrospinal fluid Anatomy 0.000 description 1
- 238000012631 diagnostic technique Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 230000005672 electromagnetic field Effects 0.000 description 1
- 210000003191 femoral vein Anatomy 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000002513 implantation Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000007917 intracranial administration Methods 0.000 description 1
- 210000003140 lateral ventricle Anatomy 0.000 description 1
- 230000003902 lesion Effects 0.000 description 1
- 238000009593 lumbar puncture Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001902 propagating effect Effects 0.000 description 1
- 210000001747 pupil Anatomy 0.000 description 1
- 238000002601 radiography Methods 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 210000000273 spinal nerve root Anatomy 0.000 description 1
- 231100000216 vascular lesion Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
- A61B5/4869—Determining body composition
- A61B5/4875—Hydration status, fluid retention of the body
- A61B5/4878—Evaluating oedema
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medical Informatics (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Physics & Mathematics (AREA)
- Molecular Biology (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Apparatus For Radiation Diagnosis (AREA)
Abstract
The invention relates to a puncture site hematoma detection platform, which comprises: one end of the arterial blood drawing tube body is punctured in the patient body, and the other end of the arterial blood drawing tube body is connected with a blood receiving port of a blood replacement mechanism of the artificial liver; the venous blood feeding tube body is provided with one end which is punctured in a patient body and the other end which is connected with a blood conveying port of a blood replacement mechanism of the artificial liver, and the punctured human body part of the venous blood feeding tube body is adjacent to the punctured human body part of the arterial blood feeding tube body; and the field video recording mechanism is arranged on the tube body of the artery blood drawing tube body and is used for executing field video recording actions on the punctured human body part of the vein blood feeding tube body and the punctured human body part of the artery blood feeding tube body. The puncture part hematoma detection platform is safe, reliable and convenient to operate. The hematoma existence condition of each blood vessel puncture part of the artificial liver can be detected and identified, so that the effective identification of various states such as hematoma existence, hematoma excess, hematoma absence and the like can be performed.
Description
Technical Field
The invention relates to the field of blood vessel puncture, in particular to a puncture part hematoma detection platform.
Background
Puncture, a commonly used medical operating term, is a diagnostic technique in which a puncture needle is inserted into a body cavity to extract secretions for testing, gas or contrast agents are injected into the body cavity to perform contrast examination, or medicines are injected into the body cavity. The purpose of puncture is to take blood for examination, blood transfusion, fluid infusion and to put in a catheter for angiography.
For example, ventricular puncture can be classified into anterior horn puncture, lateral horn puncture, and posterior horn puncture. The skull is quickly drilled through 2 cm behind the anterior hairline and 2.5 cm beside the midline by using a skull awl, and then a lumbar puncture needle or a ventricular drainage tube is used for puncturing the anterior horn of the lateral ventricle. When the cerebral hypertension is too high, the patient is coma, the pupil is enlarged, the respiratory surface is shallow, and the cerebral hernia is formed, the rapid ventricular puncture is carried out to release the ventricular fluid, and the cerebral hernia can be immediately relieved. The ventricular pressure can be measured, or a drainage bottle is connected to conduct ventricular continuous drainage, ventricular fluid is taken for assay, and methylene blue can be injected to know the circulation condition of cerebrospinal fluid. Air, oxygen and contrast agent can be injected from the puncture needle to diagnose intracranial space occupying lesion and ventricular system obstruction. Contrast should not be done for patients with iodine allergy. The ventricular fluid drains from the Shaanxi and occasionally causes epidural and subdural hematoma.
Disclosure of Invention
In order to solve the technical problems in the related art, the invention provides a puncture site hematoma detection platform which is used for detecting and identifying the existence of hematoma at each vascular puncture site of an artificial liver on the basis of targeted on-site signal processing so as to effectively identify various states of hematoma existence, hematoma excess, hematoma absence and the like.
For this reason, the present invention needs to have several important points:
(1) meanwhile, hematoma detection is carried out on the artery puncture part and the vein puncture part of the artificial liver, so that corresponding instruction notification operation is executed when a large hematoma object is identified;
(2) one or more hematoma objects are searched in the targeted processed live image based on the reference hematoma pattern, and an hyperinflammation instruction is issued when there are hematoma objects occupying an out-of-proportion limit of the image.
According to an aspect of the present invention, there is provided a puncture site hematoma detection platform, the platform comprising:
one end of the arterial blood drawing tube body is punctured in the patient body, and the other end of the arterial blood drawing tube body is connected with a blood receiving port of a blood replacement mechanism of the artificial liver;
the venous blood feeding tube body is provided with one end which is punctured in a patient body and the other end which is connected with a blood conveying port of a blood replacement mechanism of the artificial liver, and the punctured human body part of the venous blood feeding tube body is adjacent to the punctured human body part of the arterial blood feeding tube body;
the field video recording mechanism is arranged on the tube body of the arterial blood drawing tube body and is used for executing field video recording action on the punctured human body part of the venous blood feeding tube body and the punctured human body part of the arterial blood feeding tube body so as to obtain a puncture part image corresponding to the current moment;
the dynamic processing equipment is connected with the field video recording mechanism, arranged in a control box of the artificial liver and used for executing white balance processing based on a dynamic threshold value on the received puncture part image so as to obtain and output a corresponding dynamic processing image;
the data sharpening device is connected with the dynamic processing device and is used for carrying out spatial differentiation sharpening processing on the received dynamic processing image so as to obtain and output a corresponding data sharpened image;
the contrast retaining device is connected with the data sharpening device and is used for carrying out the processing of retaining the boundary of two parts with obvious colors or bright and dark contrasts in the received data sharpened image so as to obtain and output a corresponding contrast retained image;
the hematoma identification mechanism is connected with the contrast retaining device, is arranged in a control box of the artificial liver, and is used for searching one or more hematoma objects in the contrast retaining image based on a reference hematoma pattern and sending out a hematoma overlarge instruction when a hematoma object occupying the contrast retaining image with the ratio exceeding the limit exists;
wherein the hematoma identification mechanism is further configured to issue a hematoma presence instruction when a hematoma subject is present but there is no hematoma subject occupying an out-of-proportion limit of the contrast preserving image.
According to another aspect of the present invention, there is also provided a puncture site hematoma detection method, which includes using a puncture site hematoma detection platform as described above, for performing on-site detection of a hematoma existence state simultaneously at an arterial puncture site and a venipuncture site of an artificial liver.
The puncture part hematoma detection platform is safe, reliable and convenient to operate. The hematoma existence condition of each blood vessel puncture part of the artificial liver can be detected and identified, so that the effective identification of various states such as hematoma existence, hematoma excess, hematoma absence and the like can be performed.
Detailed Description
Embodiments of the puncture site hematoma detection platform of the present invention will be described in detail below.
Such as femoral artery puncture, femoral vein puncture, and subclavian vein puncture are common. The purpose is blood drawing test, blood transfusion, fluid transfusion (including the retention of infusion in the catheter) and the angiography of the catheter. Three blood vessels can be punctured for blood drawing. The subclavian vein can be punctured and then kept by placing a catheter, and can be used for venous high nutrition treatment. The puncture femoral artery implantation catheter can be used for cardio-cerebrovascular radiography.
For example, cerebral angiography, puncture of the femoral artery, catheter placement under the screen of the television near the aortic arch, common carotid or vertebral artery openings, pressurized injection of contrast agents, and rapid slide exchange of images of the cerebral vessels in the arterial, capillary and venous phases to diagnose supratentorial tumors and vascular lesions.
For example, spinal angiography is performed by inserting a catheter into the femoral artery by the seldinger method, and performing cervical and upper thoracic spinal artery angiography by delivering the catheter to the vertebral artery or the spinal root artery under an X-ray view screen. And (5) conveying the catheter to the root artery of the 4 th to 7 th intercostal artery for middle thoracic spinal artery angiography. And (3) conveying the catheter to the root arteries of the 9 th to 12 th intercostal arteries and the 1 st to 2 nd lumbar arteries, and performing thoracic or lumbar spinal artery angiography. Can be used for diagnosing spinal cord vascular malformation, intramedullary tumor, and obliterative spinal cord angiopathy. Is generally safe and has few complications.
However, in the prior art, the existence of hematoma at each vascular puncture site of the artificial liver cannot be detected and identified, so that various states such as the existence of hematoma, the excessive hematoma and the absence of hematoma can be effectively identified.
In order to overcome the defects, the invention builds a detection platform for hematoma at the puncture part, and can effectively solve the corresponding technical problem.
A puncture site hematoma detection platform shown according to an embodiment of the present invention includes:
one end of the arterial blood drawing tube body is punctured in the patient body, and the other end of the arterial blood drawing tube body is connected with a blood receiving port of a blood replacement mechanism of the artificial liver;
the venous blood feeding tube body is provided with one end which is punctured in a patient body and the other end which is connected with a blood conveying port of a blood replacement mechanism of the artificial liver, and the punctured human body part of the venous blood feeding tube body is adjacent to the punctured human body part of the arterial blood feeding tube body;
the field video recording mechanism is arranged on the tube body of the arterial blood drawing tube body and is used for executing field video recording action on the punctured human body part of the venous blood feeding tube body and the punctured human body part of the arterial blood feeding tube body so as to obtain a puncture part image corresponding to the current moment;
the dynamic processing equipment is connected with the field video recording mechanism, arranged in a control box of the artificial liver and used for executing white balance processing based on a dynamic threshold value on the received puncture part image so as to obtain and output a corresponding dynamic processing image;
the data sharpening device is connected with the dynamic processing device and is used for carrying out spatial differentiation sharpening processing on the received dynamic processing image so as to obtain and output a corresponding data sharpened image;
the contrast retaining device is connected with the data sharpening device and is used for carrying out the processing of retaining the boundary of two parts with obvious colors or bright and dark contrasts in the received data sharpened image so as to obtain and output a corresponding contrast retained image;
the hematoma identification mechanism is connected with the contrast retaining device, is arranged in a control box of the artificial liver, and is used for searching one or more hematoma objects in the contrast retaining image based on a reference hematoma pattern and sending out a hematoma overlarge instruction when a hematoma object occupying the contrast retaining image with the ratio exceeding the limit exists;
wherein the hematoma identification mechanism is further configured to issue a hematoma presence instruction when a hematoma subject is present but there is no hematoma subject occupying an out-of-proportion limit of the contrast preserving image.
Next, a specific configuration of the platform for detecting hematoma at a puncture site according to the present invention will be further described.
Among the puncture site hematoma testing platform:
the hematoma identification mechanism is further configured to issue a hematoma undetected instruction when no hematoma subject is present.
The puncture site hematoma detection platform can further comprise:
a data storage means connected to the hematoma identification means and configured to store the reference hematoma pattern in advance;
and the ZIGBEE communication interface is respectively connected with the dynamic processing device, the data sharpening device and the contrast retaining device and is used for reporting the respective abnormal states of the dynamic processing device, the data sharpening device and the contrast retaining device to a server of a medical management center.
Among the puncture site hematoma testing platform:
the data sharpening device, the contrast retaining device and the hematoma identification mechanism are realized by the same CPLD chip.
Among the puncture site hematoma testing platform:
the data sharpening device, the contrast retaining device and the hematoma identification mechanism are respectively realized by adopting logic control parts at different positions in the CPLD chip;
wherein the dynamic processing device, the data sharpening device and the contrast preserving device are respectively connected with the same clock generation mechanism.
The puncture site hematoma detection platform can further comprise:
and the NFC configuration interface is connected with the data sharpening device and is used for configuring various operating parameters for the data sharpening device based on an NFC communication link.
Among the puncture site hematoma testing platform:
the NFC configuration interface is further connected to the contrast preserving device and configured to configure various operating parameters for the contrast preserving device based on the NFC communication link.
Among the puncture site hematoma testing platform:
the NFC configuration interface is further connected with the hematoma identification mechanism and used for configuring various operation parameters for the hematoma identification mechanism based on an NFC communication link.
Among the puncture site hematoma testing platform:
in the NFC configuration interface, the data sharpening device, the contrast preservation device, and the hematoma identification mechanism have different configuration numbers;
wherein the NFC configuration interface is configured to distinguish the data sharpening device, the contrast preserving device and the hematoma identification mechanism when the NFC configuration interface performs operating parameter configuration;
the NFC configuration interface is internally provided with a timer and a clock generator.
Meanwhile, in order to overcome the defects, the invention also provides a puncture part hematoma detection method, which comprises the step of using the puncture part hematoma detection platform for carrying out field detection on the hematoma existing state of the arterial puncture part and the venous puncture part of the artificial liver at the same time.
In addition, Near Field Communication (NFC) is an emerging technology, devices (such as mobile phones) using the NFC technology can exchange data when they are close to each other, and is integrated and evolved from non-contact Radio Frequency Identification (RFID) and interconnection technology, and by integrating functions of an induction card reader, an induction card and point-to-point Communication on a single chip, applications such as mobile payment, electronic ticketing, door access, mobile identity recognition, anti-counterfeiting and the like are realized by using a mobile terminal.
The chinese language of NFC is all called near field communication technology. The NFC is developed by combining a wireless interconnection technology on the basis of a non-contact Radio Frequency Identification (RFID) technology, and provides a very safe and fast communication mode for various electronic products which are more and more popular in daily life. The "near field" in the NFC chinese name refers to radio waves in the vicinity of an electromagnetic field. Since radio waves are actually electromagnetic waves, it follows maxwell's equations, and electric and magnetic fields alternately perform energy conversion all the time during the process of propagating from a transmitting antenna to a receiving antenna and enhance each other when performing the conversion, for example, radio signals used by a human handset propagate by using the principle, which is called far-field communication. Within 10 wavelengths of electromagnetic waves, the electric field and the magnetic field are independent from each other, the electric field has little meaning, but the magnetic field can be used for short-distance communication, which is called near field communication.
The near field communication service combines the near field communication technology and the mobile communication technology, realizes multiple functions of electronic payment, identity authentication, ticketing, data exchange, anti-counterfeiting, advertisement and the like, and is a novel service in the field of mobile communication. The near field communication service enhances the functions of the mobile phone, so that the consumption behavior of the user gradually becomes electronization, and a novel user consumption and service mode is established.
In the description herein, references to the description of the term "one embodiment," "some embodiments," "an example," "a specific example," or "some examples," etc., mean that a particular feature, structure, material, or characteristic described in connection with the embodiment or example is included in at least one embodiment or example of the invention.
Furthermore, the terms "first", "second" and "first" are used for descriptive purposes only and are not to be construed as indicating or implying relative importance or implicitly indicating the number of technical features indicated. Thus, a feature defined as "first" or "second" may explicitly or implicitly include at least one such feature.
Although the present invention has been described with reference to the above embodiments, it should be understood by those skilled in the art that various changes may be made and equivalents may be substituted without departing from the spirit and scope of the invention. Therefore, the protection scope of the present invention should be subject to the scope defined by the claims of the present application.
Claims (6)
1. A puncture site hematoma detection platform, comprising:
one end of the arterial blood drawing tube body is punctured in the patient body, and the other end of the arterial blood drawing tube body is connected with a blood receiving port of a blood replacement mechanism of the artificial liver;
the venous blood feeding tube body is provided with one end which is punctured in the body of a patient and the other end which is connected with a blood conveying port of a blood replacement mechanism of the artificial liver, and the punctured human body part of the venous blood feeding tube body is adjacent to the punctured human body part of the arterial blood drawing tube body;
the field video recording mechanism is arranged on the tube body of the arterial blood drawing tube body and is used for executing field video recording actions on the punctured human body part of the venous blood feeding tube body and the punctured human body part of the arterial blood drawing tube body so as to obtain a puncture part image corresponding to the current moment;
the dynamic processing equipment is connected with the field video recording mechanism, arranged in a control box of the artificial liver and used for executing white balance processing based on a dynamic threshold value on the received puncture part image so as to obtain and output a corresponding dynamic processing image;
the data sharpening device is connected with the dynamic processing device and is used for carrying out spatial differentiation sharpening processing on the received dynamic processing image so as to obtain and output a corresponding data sharpened image;
the contrast retaining device is connected with the data sharpening device and is used for carrying out the processing of retaining the boundary of two parts with obvious colors or bright and dark contrasts in the received data sharpened image so as to obtain and output a corresponding contrast retained image;
the hematoma identification mechanism is connected with the contrast retaining device, is arranged in a control box of the artificial liver, and is used for searching one or more hematoma objects in the contrast retaining image based on a reference hematoma pattern and sending out a hematoma overlarge instruction when a hematoma object occupying the contrast retaining image with the ratio exceeding the limit exists;
wherein the hematoma identification mechanism is further configured to issue a hematoma presence instruction when a hematoma subject is present but there is no hematoma subject occupying an out-of-proportion limit of the contrast preserving image;
the hematoma identification mechanism is further used for sending out a hematoma undetected instruction when no hematoma object exists;
a data storage means connected to the hematoma identification means and configured to store the reference hematoma pattern in advance;
a ZIGBEE communication interface, which is respectively connected with the dynamic processing device, the data sharpening device and the contrast retaining device, and is used for reporting respective abnormal states of the dynamic processing device, the data sharpening device and the contrast retaining device to a server of a medical management center;
the data sharpening device, the contrast retaining device and the hematoma identification mechanism are realized by the same CPLD chip.
2. The puncture site hematoma detection platform of claim 1, wherein:
the data sharpening device, the contrast retaining device and the hematoma identification mechanism are respectively realized by adopting logic control parts at different positions in the CPLD chip;
wherein the dynamic processing device, the data sharpening device and the contrast preserving device are respectively connected with the same clock generation mechanism.
3. The puncture site hematoma detection platform of claim 2, wherein the platform further comprises:
and the NFC configuration interface is connected with the data sharpening device and is used for configuring various operating parameters for the data sharpening device based on an NFC communication link.
4. The puncture site hematoma detection platform of claim 3, wherein:
the NFC configuration interface is further connected to the contrast preserving device and configured to configure various operating parameters for the contrast preserving device based on the NFC communication link.
5. The puncture site hematoma detection platform of claim 4, wherein:
the NFC configuration interface is further connected with the hematoma identification mechanism and used for configuring various operation parameters for the hematoma identification mechanism based on an NFC communication link.
6. The puncture site hematoma detection platform of claim 5, wherein:
in the NFC configuration interface, the data sharpening device, the contrast preservation device, and the hematoma identification mechanism have different configuration numbers;
wherein the NFC configuration interface is configured to distinguish the data sharpening device, the contrast preserving device and the hematoma identification mechanism when the NFC configuration interface performs operating parameter configuration;
the NFC configuration interface is internally provided with a timer and a clock generator.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010616382.6A CN112274107B (en) | 2020-07-01 | 2020-07-01 | Puncture site hematoma detection platform |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202010616382.6A CN112274107B (en) | 2020-07-01 | 2020-07-01 | Puncture site hematoma detection platform |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN112274107A CN112274107A (en) | 2021-01-29 |
| CN112274107B true CN112274107B (en) | 2021-10-22 |
Family
ID=74420099
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202010616382.6A Active CN112274107B (en) | 2020-07-01 | 2020-07-01 | Puncture site hematoma detection platform |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112274107B (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1907225A (en) * | 2005-08-05 | 2007-02-07 | Ge医疗系统环球技术有限公司 | Process and apparatus for dividing intracerebral hemorrhage injury |
| JP2009136436A (en) * | 2007-12-05 | 2009-06-25 | Terumo Corp | Internal hemorrhage detecting apparatus and blood component collecting apparatus |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US8548570B2 (en) * | 2004-11-29 | 2013-10-01 | Hypermed Imaging, Inc. | Hyperspectral imaging of angiogenesis |
| WO2006121833A2 (en) * | 2005-05-06 | 2006-11-16 | Infrascan Inc. | System and method for detection of hematoma |
| WO2013186780A1 (en) * | 2012-06-13 | 2013-12-19 | Hadasit Medical Research Services And Development Ltd. | Devices and methods for detection of internal bleeding and hematoma |
| CN111803327B (en) * | 2020-07-02 | 2022-09-09 | 山东康盛医疗器械有限公司 | Skeleton stretching system based on human body part detection and corresponding terminal |
-
2020
- 2020-07-01 CN CN202010616382.6A patent/CN112274107B/en active Active
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1907225A (en) * | 2005-08-05 | 2007-02-07 | Ge医疗系统环球技术有限公司 | Process and apparatus for dividing intracerebral hemorrhage injury |
| JP2009136436A (en) * | 2007-12-05 | 2009-06-25 | Terumo Corp | Internal hemorrhage detecting apparatus and blood component collecting apparatus |
Also Published As
| Publication number | Publication date |
|---|---|
| CN112274107A (en) | 2021-01-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10165956B2 (en) | Compartment syndrome monitoring systems and methods | |
| Nougaret et al. | The use of MR imaging in treatment planning for patients with rectal carcinoma: have you checked the “DISTANCE”? | |
| Shellock et al. | MR labeling information for implants and devices: explanation of terminology | |
| US9332922B2 (en) | Solution for internal monitoring of body | |
| US20180271401A1 (en) | Rfid markers and systems and methods for identifying and locating them | |
| US20050054913A1 (en) | Adaptive tracking and MRI-guided catheter and stent placement | |
| CN102283650B (en) | Medical image diagnosis apparatus and image information processing apparatus | |
| CN216933458U (en) | Object recognition and needle guidance system | |
| US20170209048A1 (en) | Remote vital sign detection device and system for non-implantable medical devices and related methods | |
| CN110621215A (en) | Implantable unique device identification and detection system | |
| US11602322B2 (en) | Ischemic stroke detection and classification method based on medical image, apparatus and system | |
| CN112274107B (en) | Puncture site hematoma detection platform | |
| van Laarhoven et al. | Method for quantitation of dynamic MRI contrast agent uptake in colorectal liver metastases | |
| US20090299191A1 (en) | Extravasation Detection In An Ultrasound System | |
| Liu et al. | Similar therapeutic effects of 125I seed radiotherapy and γ-ray radiotherapy on lacrimal gland adenoid cystic carcinoma | |
| KR20190052396A (en) | System and method for monitoring biliary obstruction | |
| Gagliardi et al. | How to transform an aortic valve prostheses into an UHF antenna for the RFID-based wireless monitoring of the cardiac health | |
| Hui et al. | Accurate extraction of heartbeat intervals with near-field coherent sensing | |
| Wolfs et al. | Visualization of both the superficial and deep lymphatic system of the upper extremity using magnetic resonance lymphography | |
| CN109766852B (en) | Automatic medical service platform | |
| Abbosh et al. | Microwave techniques as diagnostic tool for congestive heart failure | |
| US20200268256A1 (en) | Injectable biocompatible sensor system for measuring and communicating physiological data | |
| Pandey et al. | A method for rapid clinical diagnosis of misplaced subclavian vein catheters | |
| CN110910361A (en) | Intravascular stent based detection method and device | |
| Bravo et al. | Ultrasound‐guided poly‐l‐lactic acid nodule excision: The importance of the injector ultrasonographic experience |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant | ||
| TR01 | Transfer of patent right | ||
| TR01 | Transfer of patent right |
Effective date of registration: 20221209 Address after: No.2888, Zhonghua West Road, hi tech Zone, Heze City, Shandong Province 274000 Patentee after: GUOJIUTANG SHANDONG DONKEY-HIDE GELATIN CO.,LTD. Address before: 215000 no.363 Lushan Road, Suzhou hi tech Industrial Development Zone, Suzhou, Jiangsu Province Patentee before: Du Xinglin |
|
| CP01 | Change in the name or title of a patent holder | ||
| CP01 | Change in the name or title of a patent holder |
Address after: No.2888, Zhonghua West Road, hi tech Zone, Heze City, Shandong Province 274000 Patentee after: Shandong Guojiutang Pharmaceutical Group Co.,Ltd. Address before: No.2888, Zhonghua West Road, hi tech Zone, Heze City, Shandong Province 274000 Patentee before: GUOJIUTANG SHANDONG DONKEY-HIDE GELATIN CO.,LTD. |